Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.01.462697Source: DataRank Database

Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (56)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Xin Yang ORCID,Eric Ma ORCID,Margarita Gutova ORCID,Christine E. Brown ORCID,Russell C. Rockne ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W3201794047

National Institutes of Health

Grant: 5R01NS115971-04

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

National Institutes of Health

Grant: 5R01CA254271-02

Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

National Institutes of Health

Grant: 5R01DK000562-34

METABOLIC MECHANISMS

greenLicense: cc-by

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/12/21/2021.10.01.462697.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.10.01.462697

repositoryhttps://doi.org/10.1101/2021.10.01.462697

https://doi.org/10.1371/journal.pcbi.1009504

Fields of Study

CAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsMathematical Biology Tumor Growth03 medical and health sciences0302 clinical medicine

Keywords

DexamethasoneChimeric antigen receptorGlucocorticoid receptorImmunotherapyCytotoxic T cellIn vitroClearanceCell cultureCellCell growthGlucocorticoidCancer researchBiologyChemistryMedicineCell biologyImmunologyEndocrinologyImmune systemBiochemistryAdultMaleBioinformaticsQH301-705.5Oncology and CarcinogenesisAdoptive610Immunotherapy, AdoptiveMathematical Sciences510Cell LineRare DiseasesInformation and Computing SciencesCell Line, TumorReceptorsGeneticsHumansBiology (General)CancerTumorReceptors, Chimeric AntigenBiomedical and Clinical SciencesChimeric AntigenGene TherapyBiological SciencesMiddle AgedBrain DisordersBrain CancerGlioblastomaBiotechnologyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being